Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,640 | -834 | -3,969 | -1,740 | -3,620 |
| Depreciation Amortization | 8 | 2 | N/A | N/A | 2 |
| Accounts receivable | N/A | N/A | -719 | -160 | N/A |
| Accounts payable and accrued liabilities | 474 | 27 | 220 | -192 | N/A |
| Other Working Capital | 260 | 23 | -499 | -352 | -1,880 |
| Other Operating Activity | -562 | -27 | 591 | 396 | 48 |
| Operating Cash Flow | $-9,460 | $-809 | $-4,376 | $-2,048 | $-5,450 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -142 | N/A | N/A |
| PPE Investments | -50 | N/A | N/A | N/A | 0 |
| Other Investing Activity | -140 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-190 | $N/A | $-142 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 432 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | -7 | N/A | N/A | N/A |
| Common Stock Issued | 3,691 | 237 | N/A | 8,219 | N/A |
| Other Financing Activity | 4,087 | 112 | 8,219 | 0 | 12,000 |
| Financing Cash Flow | $8,210 | $342 | $8,219 | $8,219 | $12,000 |
| Exchange Rate Effect | N/A | -34 | N/A | N/A | 0 |
| Beginning Cash Position | 7,650 | 554 | 7,657 | 7,657 | 1,100 |
| End Cash Position | 6,210 | 53 | 11,358 | 13,828 | 7,650 |
| Net Cash Flow | $-1,440 | $-501 | $3,701 | $6,171 | $6,550 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,460 | -809 | -4,376 | -2,048 | -5,450 |
| Free Cash Flow | -9,460 | -809 | -4,376 | -2,048 | -5,450 |